Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04 avr. 2024 08h11 HE
|
Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
02 avr. 2024 07h30 HE
|
Optimi Health Corp.
Optimi receives Certificate Of Analysis for GMP Natural Psilocybin Extract. Company has also completed the in-house encapsulation of 5mg & 10mg psilocybin.
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
28 mars 2024 07h30 HE
|
Optimi Health Corp.
Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
25 mars 2024 07h48 HE
|
MetasTx LLC
Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.
Animal Biotechnology Market Report 2024-2029, Featuring Profiles of Zeus Biotech, Invetx, Ingenta Connect, Kingfisher Biotech, Animab, Boehringer Ingelheim, RSPCA, Santa Cruz Biotechnology and Pfizer
20 mars 2024 13h37 HE
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Animal Biotechnology Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The animal biotechnology market...
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
20 mars 2024 10h20 HE
|
PharmAla Biotech
PharmAla Recieves Notice of Allowance of Patent on Novel MDMA-like Molecule with improved safety, therapeutic range
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
18 mars 2024 08h55 HE
|
PharmAla Biotech
PharmAla's 50:50 Joint Venture with Vitura Health Limited, Cortexa, announces it is first entity to supply Psilocybin into Authorized Prescriber Scheme
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024: Deals Listed by Company A-Z, Headline Value, Therapeutic Area, and Technology Type
08 mars 2024 07h44 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.Joint Venture Deals in...
Bioprocess Validation Global Strategic Business Report 2024: Rise of Pharma Contract Manufacturing Present Growth Opportunities for Bioprocess Validation Outsourcing to Emerging Markets
01 mars 2024 06h48 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Bioprocess Validation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bioprocess Validation...
Global Marine Biotechnology Strategic Business Report 2024: Market to Reach $13.1 Billion by 2030 - Focus on Biofuels as the Future Energy Security Solution Drives Strong Demand
21 févr. 2024 06h12 HE
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Marine Biotechnology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Marine Biotechnology Market...